The purpose of the present invention is to provide an ophthalmic composition for a zwitterionic soft contact lens that includes pranoprofen and/or a salt thereof, wherein the external appearance is clear, and adsorption to the zwitterionic soft contact lens including pranoprofen and/or a salt thereof is suppressed. An ophthalmic composition for a zwitterionic soft contact lens that includes pranoprofen and/or a salt thereof, wherein trometamol is combined, a clear external appearance can be achieved by setting the pH at 5.5 or more, and adsorption to the zwitterionic soft contact lens including pranoprofen and/or a salt thereof can be effectively suppressed.
